| |
The purpose of the 3-day Deming Conference on Applied Statistics is to provide a learning experience on recent developments
in statistical methodologies. The conference is composed of 12 3-hour
tutorials on current statistical topics of interest based on recently published texts. The conference is followed by two 2-day parallel short courses.
The conference sells these books at a 40% discount.
Poster submissions are also solicited.
Poster Session
The Annual Deming Conference on Applied Statistics will accept submission of abstracts for poster
presentation during the conference. The poster sessions provide a forum to attendees to present concepts and
issues of relevance to their peers. The rules and tips of the poster presentations can be found by clicking the button below.
or click here to download the pdf file.
Program Summary
The 73rd Deming Conference will be held on December 4-8, 2017 at Atlantic City, NJ.
There will be two parallel half-day tutorial sessions based on recently published
books for the first three days for a total of 12 tutorial sessions (December 5, 6, 7). Then the conference will continue
with two 2-day short courses on December 8 and December 9.
The books used
for the tutorial sessions and for the short courses as well as books written by invited speakers
will be sold at an appreciable discounted prices.
The authors of the books are invited as the speakers.
Poster sessions will also be presented. A complete program pdf file will be available for download.
|
| |
The 73rd Deming Conference Program
Poster sessions will be in the middle of the 3 extended tutorial sessions
(Monday afternoon, and Tuesday and Wednesday Morning)
Click topic titles for abstracts and speaker names for bios
|
| | | 12/4/2017 (Monday) | | 6:30 AM - 8:00 AM | Registration
|
| | | 7:00 AM - 8:00 PM | Full Hot Breakfast (Covered by registration fee)
|
| | | 8:00 AM - 9:00 AM | Session Keynote
Roles of Biostatisticians In New Drug Development and Regulatory Review
Dr. Yuki Ando, Senior Scientist for Biostatistics
Pharmaceuticals and Medical Devices Agency, Japan |
| | | 9:00 AM - 12:00 Noon | Session A(based on book)
Hot Topics in Clinical Trials: Multiple Outcomes and Benefit: Risk
Dr. Toshimitsu Hamasaki, National Cerebral and Cardiovascular Center
Dr. Scott R. Evans, Harvard University
|
| | | Session B
Missing Data Analysis Using SAS®
Dr. Frank Liu, Merck & Co. Inc.
Dr. Fang Chen, SAS Institute |
| | | 12:00 Noon - 1:30 PM | Lunch Break (on your own)
|
| | | 1:30 PM - 4:45 PM | Session C
Regulatory Science and Drug Development in China
Professor Naiqing Zhao, Fudan University
Dr. Jie Chen, Merck Research Laboratories
|
| | | Session D(based on book)
Phase II Clinical Development of Drugs
Dr. Naitee Ting (Boehringer Ingleheim)
Dr. Shuyen Ho (UCB) |
| | | 7:00 PM | Session Speaker Dinner
Speaker Dinner and Student Awards (optional, fee added)
click here for Student Awards Abstracts (to be presented during Poster Sessions)
|
| | | 12/5/2017 (Tuesday) | | 6:00 AM - 8:00 AM | Registration
|
| | | 7:00 AM - 8:00 AM | Full Hot Breakfast (Covered by registration fee)
|
| | | 8:00 AM - 9:00 AM | Session Keynote
Bridging Study Evaluation and MRCTs in Taiwan: Regulatory Perspectives and Experiences
Dr. Guei-Feng Tsai, Statistical Team Leader
Division of New Drugs, Center for Drug Evaluation; Taiwan |
| | | 9:00 AM - 12:15 PM | Session E(based on book)
Generalized Linear Models
Alan Agresti, Distinguished Professor Emeritus, University of Florida |
| | | Session F
Likelihood-Based Methods for Continuous Safety Monitoring of Pharmaceutical Products
Dr. William Wang (Merck),
Dr. Krishan P. Singh (GSK)
Dr. Ram Tiwari (FDA))
On Behalf of the ASA Safety Monitoring Working Group |
| | | 12:15 PM -1:45 PM | Lunch Break (on your own)
|
| | | 1:45 PM - 4:45 PM | Session G
Multi-Regional Clinical Trials and the ICH E17
Dr William Wang (Merck)
Dr Bruce Binkowitz (Shionogi)
Dr Yuki Ando (PMDA) |
| | | Session H (Canceled, replaced with Session L)
Causal Inference in a Big Data World: Introduction to Parametric and
Semi-Parametric Estimators for Causal Inference
Dr. Laura Balzer, Assistant Professor of Biostatistics at the University of Massachusetts, Amherst |
| | | 12/6/2017 (Wednesday) | | 6:30 AM - 8:00 AM | Registration
|
| | | 7:00 AM - 8:00 AM | Full Hot Breakfast (Covered by registration fee)
|
| | | 8:00 AM - 9:00 AM | Session Keynote
Regulatory Hot Topics in Europe
Frank Pétavy and Andrew Thomson , Biostatistics and Methodology Support
R&D Division, European Medicines Agency, London, UK |
| | | 9:00 AM - 12:15 PM | Session I
Benefit–Risk Assessment and Utility of Real World Evidence in
Medical Product Development and Life Cycle Management
Dr. Weili He, Abbvie
Dr. Qi Jiang, Amgen. |
| | | Session J
Dose-Finding in Clinical Development
Dr. Qiqi Deng, Boehringer Ingleheim |
| | | 12:15 PM - 1:45 PM | Lunch Break (on your own)
|
| | | 1:45 PM - 4:45 PM | Session K
Statistical & Strategic Considerations in Development of Oncology Immunotherapies
Dr. Cong Chen, Merk & Co. |
| | | Session L (moved up to Tuesday Session H)(based on book)
Meta-Analysis and Network Meta-Analysis in Clinical Trials
Dr. Joseph C. Cappelleri, Pfizer Inc
Prof. Ding-Geng (Din) Chen, University of North Carolina at Chapel Hill |
| | | 12/7/2017 - 12/8/2017 (Thursday and Friday) | | 6:30 AM - 8:00 AM | Registration
|
| | | 7:00 AM - 8:00 AM | Full Hot Breakfast (Covered by Short Course registration fee)
|
| | 8:00 AM - 5:50 PM (Thu)
8:00 AM - 1:30 PM (Fri) | Short Course 1
GUIDE Approach to Subgroup Identification and Analysis for Precision Medicine
Prof. Wei-Yin Loh, University of Wisconsin |
| | 8:00 AM - 5:50 PM (Thu)
8:00 AM - 1:30 PM (Fri) | Short Course 2(based on book)
Multiplicity Issues in Clinical Trials
Dr. Alex Dmitrienko, Mediana Inc |
| |
| |
| The following books will be used and sold during the conference.
Please order the books through the registration page. You should not order the book used
for the short course you registered unless you want to order extra copies.
|
| Book Information (Author, Title, etc.) |
Price (USD) |
| List |
Discount |
| Springer | | Naitee Ting, Ding-Geng Chen, Shuyen Ho, and Joseph C. Cappelleri, Phase II Clinical Development of New Drugs (1 st Edition), 2017, 250 Pages, ISBN: 978-981-10-4194-5 | 109 | 68 | | Hamasaki, T., Evans, S.R.Asakura, K., and Ochiai, T., , Group-Sequential Clinical Trials with Multiple Co-Objectives (1st Edition), 2016, 110 Pages, ISBN: 978-4-431-55900-9 | 54.99 | 36 | | Sozu, T., Sugimoto, T., Hamasaki, T., and Evans, S.R., Sample Size Determination in Clinical Trials with Multiple Endpoints (1st Edition), 2015, 80 Pages, ISBN: 978-3-319-22005-5 | 69.99 | 45 | | John Wiley | | Alan Agresti, Foundations of Linear and Generalized Linear Models (1st Edition), 2015, 472 Pages, ISBN: 978-1-118-73003-4 | 125 | 74 | | Taylor and Francis | | Ding-Geng (Din) Chen, and Karl E. Peace, Applied Meta-Analysis with R (1st Edition), 2013, 342 Pages, ISBN: 9781466505995 | 97.95 | 62 | | Alex Dmitrienko, Ajit C. Tamhane, and Frank Bretz, Multiple Testing Problems in Pharmaceutical Statistics (1 st Edition), 2009, 320 Pages, ISBN: 9781584889847 (Included in Short Course 2) | 99.95 | 63 | | Leo Breiman, Jerome Friedman, Charles J. Stone, and R.A. Olshen, Classification and Regression Trees (1 st Edition), 1984, 368 Pages, ISBN: 9780412048418 (Recommended by instructors and included in Short Course 1) | 109.95 | 69 |
|
|
